Word

OLIGOPHORE

Status

Dead

Status Code

602

Status Date

Monday, April 17, 2023

Serial Number

90750400

Mark Type

4000

Filing Date

Wednesday, June 2, 2021

Abandoned Date

Monday, April 3, 2023

Trademark Owner History

Otolanum AG

Classifications

5 Pharmaceutical preparations, namely, therapeutics comprising nucleic acids, peptides or proteins for use in the intracellular treatment or prevention of allergy, autoimmune, cardiovascular, dermatologic, endocrine, gastroenterological, hematologic, immunologic, infectious, metabolic, neurological, oncologic, ophthalmologic, otic, orthopedic, pain, pulmonary, psychiatric, mental health, respiratory, rheumatologic, urologic, and women's health diseases and disorders; Pharmaceutical preparations, namely, vaccines comprising nucleic acids, peptides or proteins for use in the intracellular treatment or prevention of diseases or disorders

42 Scientific research in the fields of therapeutics or vaccines comprising nucleic acids, peptides or proteins for use in the intracellular treatment or prevention of diseases or disorders

Trademark Events

Apr 17, 2023

Abandonment Notice E-Mailed - Failure To Respond

Apr 17, 2023

Abandonment Notice Mailed - Failure To Respond

Apr 17, 2023

Abandonment - Failure To Respond Or Late Response

Oct 1, 2022

Notification Of Final Refusal Emailed

Oct 1, 2022

Final Refusal E-Mailed

Oct 1, 2022

Final Refusal Written

Aug 18, 2022

Teas/Email Correspondence Entered

Aug 18, 2022

Correspondence Received In Law Office

Aug 18, 2022

Teas Response To Office Action Received

Feb 18, 2022

Notification Of Non-Final Action E-Mailed

Feb 18, 2022

Non-Final Action E-Mailed

Feb 18, 2022

Non-Final Action Written

Feb 10, 2022

Assigned To Examiner

Aug 26, 2021

New Application Office Supplied Data Entered

Jun 5, 2021

New Application Entered